Supplementary Methods from Targeting PI3K/mTOR Overcomes Resistance to HER2-Targeted Therapy Independent of Feedback Activation of AKT

Authors :: Dennis J. Slamon
Samit Hirawat
Richard S. Finn
Ronald Linnartz
Christian Schnell
Emmanuelle di Tomaso
Sara A. Hurvitz
Dylan Conklin
Ondrej Kalous
Erika von Euw
Luo Tong
Karen McDonald
Neil A. O'Brien
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 60K

Full Text Access

Tools